Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kashani-Sabet

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The British Journal of Dermatology|July 3, 2013
Molecular markers in melanomaM Kashani-Sabet
Journal of the American Academy of Dermatology|November 26, 1999
Toward the biologic treatment of nonmelanoma skin cancerM Kashani-Sabet
Journal of the National Cancer Institute|April 29, 1998
Ribozymes as therapeutic agents: are we getting closer?K J Scanlon, M Kashani-Sabet
Journal of the American Academy of Dermatology|August 1, 1997
Response rates in photopheresis therapy for cutaneous T-cell lymphomaH S Zackheim, M Kashani-Sabet
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cellsK J Scanlon, M Kashani-Sabet
Chemotherapy|January 1, 1989
Drug selectivity and membrane transport properties of normal human lymphocytesM Kashani-Sabet, K J Scanlon
Journal of Clinical Laboratory Analysis|January 1, 1989
Utility of the polymerase chain reaction in detection of gene expression in drug-resistant human tumorsK J Scanlon, M Kashani-Sabet
Cancer Gene Therapy|September 1, 1995
Application of ribozymes to cancer gene therapyM Kashani-Sabet, K J Scanlon
Journal of the American Academy of Dermatology|October 19, 2001
A modified staging classification for cutaneous T-cell lymphomaM Kashani-Sabet, A McMillan, H S Zackheim
Surgical Oncology Clinics of North America|July 1, 1997
Prognostic factors in malignant melanomaM Kashani-Sabet, S P Leong, R Sagebiel
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The British Journal of Dermatology|July 3, 2013
Molecular markers in melanomaM Kashani-Sabet
Journal of the American Academy of Dermatology|November 26, 1999
Toward the biologic treatment of nonmelanoma skin cancerM Kashani-Sabet
Journal of the National Cancer Institute|April 29, 1998
Ribozymes as therapeutic agents: are we getting closer?K J Scanlon, M Kashani-Sabet
Journal of the American Academy of Dermatology|August 1, 1997
Response rates in photopheresis therapy for cutaneous T-cell lymphomaH S Zackheim, M Kashani-Sabet
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cellsK J Scanlon, M Kashani-Sabet
Chemotherapy|January 1, 1989
Drug selectivity and membrane transport properties of normal human lymphocytesM Kashani-Sabet, K J Scanlon
Journal of Clinical Laboratory Analysis|January 1, 1989
Utility of the polymerase chain reaction in detection of gene expression in drug-resistant human tumorsK J Scanlon, M Kashani-Sabet
Cancer Gene Therapy|September 1, 1995
Application of ribozymes to cancer gene therapyM Kashani-Sabet, K J Scanlon
Journal of the American Academy of Dermatology|October 19, 2001
A modified staging classification for cutaneous T-cell lymphomaM Kashani-Sabet, A McMillan, H S Zackheim
Surgical Oncology Clinics of North America|July 1, 1997
Prognostic factors in malignant melanomaM Kashani-Sabet, S P Leong, R Sagebiel
Pageof 6